NCT06760481 2026-04-15Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)M.D. Anderson Cancer CenterPhase 1 Active not recruiting7 enrolled
NCT05286801 2026-04-13Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient TumorsNational Cancer Institute (NCI)Phase 1/2 Active not recruiting86 enrolled